STRONGBRIDGE BIOPHARMA plc — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2512031e-696a-4aa8-965b-7007c61f20af/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $30.7M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002288 |
| FY 2019 | $21.7M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001720 |
| FY 2018 | $18.0M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001146 |
| FY 2017 | $7.0M | 2017-01-01 – 2017-12-31 | evidence 0001558370-19-001146 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
STRONGBRIDGE BIOPHARMA plc — all facts · Net Income · Operating Income